Sobha Sivaprasad - Journalist Profile | Connect with top journalists
View 's journalist industries, journalist types, location, and media outlets. Use Journalist Hunt to get connected with top journalists in seconds.
Get connected with journalists today
Sobha Sivaprasad
Verified
Editor-in-Chief, Eye
London
Beats
Biography
Music., Style Luxury, Movies Gaming,Automotive Car Modification, Streetwear Travel, Sneakers
Entertainment and Outdoors
Content
Letter in reply to: Enhancing the understanding of anti-VEGF treatment failure in retinal vascular diseases: a call for expanded analyses and threshold validation | Eye
Infographic: Efficacy and safety of high-dose intravitreal aflibercept 8 mg in patients with diabetic macular oedema: Week 48 results from the phase 2/3 PHOTON trial | Eye
Letter in reply to: Enhancing the understanding of anti-VEGF treatment failure in retinal vascular diseases: a call for expanded analyses and threshold validation | Eye
Company Info
Eye
Eye is a monthly peer-reviewed medical journal covering ophthalmology. Established in 1881 as the Transactions of the Ophthalmological Societies of the United Kingdom, Eye obtained its current name in 1987. Eye seeks to provide the international practising ophthalmologist with high quality articles, of academic rigour, on the latest global clinical and laboratory based research. Its core aim is to advance the science and practice of ophthalmology with the latest clinical- and scientific-based research. Whilst principally aimed at the practising clinician, the journal contains material of interest to a wider readership including optometrists, orthoptists, other health care professionals and research workers in all aspects of the field of visual science worldwide. Eye encourages the submission of original articles covering all aspects of ophthalmology including: external eye disease oculo-plastic surgery orbital and lacrimal disease ocular surface and corneal disorders paediatric ophthalmology and strabismus glaucoma medical and surgical retina neuro-ophthalmology cataract and refractive surgery ocular oncology ophthalmic pathology ophthalmic genetics Our publishing models: Eye is a Transformative Journal (TJ). When research is accepted for publication, authors can choose to publish using either the traditional publishing route (fee free) OR via immediate gold Open Access. Eye is actively committed to becoming a fully Open Access journal. We will increase the number of articles we publish OA, with the eventual goal of becoming a fully Open Access journal. A journal that commits to this process is known as a Transformative Journal. 2022 Citation Metrics 2-year Impact Factor*: 3.9 5-year Impact Factor*: 4.0 *2022 Journal Citation Reports® Science Edition (Clarivate Analytics, 2023) Published by Springer Nature. The Editor-in-Chief is Prof Sobha Sivaprasad (Moorfields Eye Hospital). ISSN: 0950-222X, eISSN: 1476-5454
London, , United Kingdom
+44 87 0990 8881
Founded: 1881